Aclipse, Mayo Clinic Team Up on Trial for First Drug Aimed at Halting Gastroparesis
KING OF PRUSSIA, PA — Aclipse Therapeutics has entered a clinical collaboration with Mayo Clinic to advance a Phase 2 study of M107, a novel small-molecule drug positioned as the …
Aclipse, Mayo Clinic Team Up on Trial for First Drug Aimed at Halting Gastroparesis Read More